Which blood thinner is safest for ICU patients with kidney failure? large study aims to find out

NCT ID NCT07365644

Not yet recruiting Knowledge-focused Sponsor: Centre Hospitalier le Mans Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at ICU patients with kidney failure who need blood thinners to prevent dangerous clots. Doctors currently use different types of heparin, but it's unclear which is safest and works best when kidneys are weak. The study will track over 1,100 patients to compare bleeding risks and clot prevention across the various heparin options.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROPHYLACTIC ANTICOAGULATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

impaired renal function disease kidney failure venous thromboembolism prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROPHYLACTIC ANTICOAGULATION

Contacts and locations

Locations

CHR Metz-Thionville Hôpital Bel-Air

Thionville, 57100, France
CHR Metz-Thionville site Mercy

Metz, 57000, France
CHRU Nancy

Nancy, 54511, France
CHU Angers

Angers, 49000, France
CHU Brest

Brest, 29609, France
CHU Caen

Caen, 14000, France
CHU Nantes

Nantes, 44000, France
CHU Orléans

Orléans, 45100, France
CHU Poitiers

Poitiers, 86000, France
CHU Rennes

Rennes, 35000, France
CHU Tours

Tours, 37000, France
CHU bordeaux

Bordeaux, 33000, France
Centre Hospitalier Le Mans

Le Mans, 72000, France
Centre Hospitalier de Saint-Nazaire

Saint-Nazaire, 44600, France
Groupe Hospitalier Bretagne Sud

Lorient, 56322, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.